You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LAG-3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced NSCLC Trial in Shanghai (GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin,

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shang Hai Pulmonary Hospital
Aug 3, 2023

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)

Recruiting
  • Psoriasis
  • Atopic Dermatitis
  • UVB treatment
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

Not yet recruiting
  • Metastatic Melanoma
  • Advanced Melanoma
  • San Francisco, California
    University of California, San Francisco
Jan 13, 2023

Tumor, Solid Trial in Xiamen (68Ga-DOTA-hLAG-3 PET/CT)

Recruiting
  • Tumor, Solid
  • 68Ga-DOTA-hLAG-3 PET/CT
  • Xiamen, Fujian, China
    The First affiliated hospital of xiamen university
May 8, 2022

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Breast Carcinoma Trial in Houston (biological, drug, other)

Not yet recruiting
  • Breast Carcinoma
  • eftilagimod alpha
  • +2 more
  • Houston, Texas
    Oncology Consultants
Feb 17, 2023

Colorectal Cancer Metastatic Trial (HLX26, HLX10)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • (no location specified)
Oct 14, 2022

Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)

Recruiting
  • Neoadjuvant
  • +3 more
  • Pembrolizumab, Eftilagimod alpha
  • Warsaw, Poland
    Maria Sklodowska-Curie National Research Institute of Oncology
Nov 7, 2023

Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors(Stage IA-IB)
  • AK129 IV infusion
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Jan 17, 2023

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 10, 2022

Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

Not yet recruiting
  • Brain Ischemia
  • Serum Iron
  • +7 more
  • Aswan, Egypt
    Aswan University Hospital
Mar 7, 2023

Efficacy of Immunotherapy in Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Carcinoma
  • CTC PD-L1, exosomal PD-L1, and exosomal LAG-3 detection
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Oct 20, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Pre-Eclampsia Trial (real time PCR)

Not yet recruiting
  • Pre-Eclampsia
  • real time PCR
  • (no location specified)
Mar 22, 2022

Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Dec 20, 2022

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Relatlimab
  • Nivolumab
  • Shanghai, Shanghai, China
    Local Institution
Aug 10, 2022

Advanced Solid Tumors Trial in Beijing (BMS-986213)

Recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Mar 23, 2023

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting
  • Adult Solid Tumor
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Oct 17, 2022

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

Metastatic Breast Cancer Trial (Eftilagimod Alpha, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Aug 2, 2022